SCHEMBL24485296

SCHEMBL24485296

CC(C)NCCNc1ccccn1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.57
CYP1A2 P05177 1/20 0.54
CXCR4 P61073 1/20 0.50
FABP1 P07148 1/20 0.49
FABP6 P51161 1/20 0.49
CYP2D6 P10635 1/20 0.46
FDPS P14324 1/20 0.45
PCSK9 Q8NBP7 1/20 0.44
KDM4E B2RXH2 3/20 0.44
ALDH1A1 P00352 2/20 0.44
ALOX12 P18054 1/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
GAA P10253 1/20 0.44
TP53 P04637 1/20 0.44
TSHR P16473 1/20 0.44
HPGD P15428 1/20 0.44
ITGB3 P05106 1/20 0.42
ITGB1 P05556 1/20 0.42
ITGAV P06756 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18233631 0.90 CYP2C19 (0.54) CYP2C19CYP1A2CXCR4FABP1FABP6
SCHEMBL19091376 0.85 CYP2C19 (0.53) CYP2C19CYP1A2CXCR4FABP1FABP6
SCHEMBL3265804 0.84 CYP1A2 (0.70) CYP2C19CYP1A2CXCR4FABP1FABP6
SCHEMBL20988152 0.83 CYP2C19 (0.54) CYP2C19CYP1A2CXCR4FABP1FABP6
SCHEMBL1837886 0.81 CYP1A2 (0.66) CYP2C19CYP1A2CXCR4FABP1FABP6
SCHEMBL317566 0.80 ALDH1A1 (0.60) CYP2C19CYP1A2CXCR4FABP1FABP6
SCHEMBL1344396 0.79 CYP2C19 (0.62) CYP2C19CYP1A2CXCR4FABP1FABP6
Hydrochloric Acid SCHEMBL8177967 0.78 CYP2C19 (0.61) CYP2C19CYP1A2CXCR4FABP1FABP6
SCHEMBL7442415 0.77 CYP2C19 (0.56) CYP2C19CYP1A2CXCR4FABP1FABP6
SCHEMBL28657675 0.77 CYP2C19 (0.56) CYP2C19CYP1A2CXCR4FABP1FABP6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022112352-A1 HETEROCYCLE DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2022-06-02 WO disclosed